10:22:03 EDT Sat 27 Apr 2024
Enter Symbol
or Name
USA
CA



T:TH - THERATECHNOLOGIES INC. - http://www.theratech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TH - T  7.41.79·1.833.01.8019.031511.80  1.83  1.755.84  1.2216:00:00Apr 1515 min RT 2¢
TSX - T7.41.79·1.833.01.8014.825261.80  1.83  1.755.84  1.2216:00:0015 min
NEO ATS - U 1.83+0.031.70.5111.83  1.83  1.8311:01:2915 min
Alpha - A 1.81+0.010.62.0341.80  1.81  1.7615:59:2915 min
Pure - P 1.800.103    Apr 2515 min
Chi-X - X 1.79-0.01-0.60.8131.77  1.83  1.7711:01:0415 min
CX2 - H 1.79-0.01-0.60.1011.79  1.79  1.7912:10:0715 min
CXD - D 1.81+0.010.60.2041.81  1.81  1.8109:48:5815 min
TriAct - M 1.800.619    Sep 11-2015 min

Recent Trades - Last 10 of 51
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00T1.80 10085 Scotia1 AnonymousKQ
15:59:51T1.80 10085 Scotia79 CIBCK
15:59:51T1.80 10085 Scotia79 CIBCK
15:59:29A1.810.012001 Anonymous79 CIBCK
15:55:01T1.830.0310080 National Bank9 BMO NesbittK
15:51:47T1.80 10085 Scotia1 AnonymousK
15:03:48M1.830.0317 TD Sec7 TD Sec
14:38:32M1.830.031580 National Bank80 National BankE
14:32:20M1.79-0.01480 National Bank80 National Bank
14:22:03M1.830.03580 National Bank80 National BankE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-15 16:39C:TH1.80News ReleaseTheratechnologies mails proxy circular for May 9 AGM
2024-04-10 11:45C:TH2.09News ReleaseTheratechnologies loses $4.48-million (U.S.) in Q1
2024-04-10 07:54C:TH2.09SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-10 07:54C:TH2.09SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-10 07:54C:TH2.09SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-08 16:43C:TH1.93News ReleaseTheratechnologies presents preclinical data on SORT1+
2024-04-05 11:28C:TH2.06News ReleaseTheratechnologies appoints Tea as director
2024-04-03 11:00C:TH2.16News ReleaseTheratechnologies to release Q1 2024 results April 10
2024-03-22 10:56C:TH1.70News ReleaseTheratechnologies to cut preclinical cancer research
2024-03-21 20:06C:TH1.70News ReleaseTheratechnologies appoints Zwick as director
2024-03-21 10:52C:TH1.65News ReleaseTheratechnologies increases dose level in phase 1 trial
2024-02-29 16:38C:TH2.01News ReleaseTheratechnologies director Trudeau resigns
2024-02-27 08:30C:TH2.20News ReleaseTheratechnologies gets refusal-to-file letter from FDA
2024-02-21 11:32C:TH2.27News ReleaseTheratechnologies loses $23.95M (U.S.) in fiscal 2023
2024-02-21 08:41C:TH2.27SEDAR Annual ReportSEDAR Annual Report
2024-02-21 08:30C:TH2.27SEDAR MD & ASEDAR MD & A
2024-02-21 08:30C:TH2.27SEDAR MD & ASEDAR MD & A
2024-02-21 08:24C:TH2.27SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-02-20 12:07C:TH2.23News ReleaseTheratechnologies publishes journal article on TH1902
2024-02-15 11:25C:TH2.28News ReleaseTheratechnologies enrolls six patients in TH1902 trial